angioplasty balloon

an·gi·o·plas·ty bal·loon

a balloon near the tip of an angiographic catheter, designed to distend narrowed vessels. See: balloon-tip catheter.

an·gi·o·plas·ty bal·loon

(an'jē-ō-plas-tē bă-lūn')
A balloon near the tip of an angiographic catheter, designed to distend narrowed vessels.
See: balloon-tip catheter
References in periodicals archive ?
The $30 million deal will see SPNC buying Covidien's Stellarex drug-coated angioplasty balloon (DCB) platform.
During the procedure, the artery is first partially opened with a traditional angioplasty balloon, without a drug coating.
About Glider (TM): The Glider (TM) PTCA Balloon Catheter is the world's only torqueable angioplasty balloon catheter.
The clinical applications of Powr syringe include Angiography, Angioplasty Balloon Inflation, Gastroenterology, and Urology.
About the Moxy Drug Coated Balloon The Moxy balloon is very similar to a standard angioplasty balloon, but is coated with an anti-restenotic drug designed to help keep arteries open and free from re-blockage.
The AngioSculpt[R] represents a significant improvement over conventional angioplasty balloon catheters for the treatment of challenging lesions because of its ability to achieve more predictable luminal expansion and a lower rate of dissection.
The clinical trial will help doctors determine whether a drug coated angioplasty balloon will be more successful in keeping narrowed arteries open for longer compared to treatment with a non-coated standard angioplasty balloon.
Angioslide Secures FDA Clearance for eXtra Angioplasty Balloon
Many clinicians currently use high-cost, customized two-handed angioplasty balloon inflation devices to deliver and monitor pressure during discography procedures.
MINNEAPOLIS, July 25, 2011 /PRNewswire/ -- Lutonix today announced the first patient enrolled in the LEVANT 2 clinical trial, a global, multicenter, randomized trial evaluating the safety and efficacy of the Moxy(TM) Drug Coated Balloon compared to a standard angioplasty balloon for the treatment of peripheral arterial disease (PAD).
The D2B campaign gives hospitals guidelines and suggestions on how to reduce a cardiac arrest patient's door-to-balloon time -- the amount of time between a patient's initial arrival at the hospital and the opening of the blocked artery with an angioplasty balloon.
The global angioplasty balloon market has been segmented on the basis of product type, material, and geography.